Table of Contents
Introduction
Overview
Factors Promoting Deal Activity
Key Strategies Implemented in Deals
Geographical Expansion
Portfolio Enhancement
Market Consolidation
Improving Research and Development
Product Lifecycle management
Entry into Rare disease Markets
Deal Types
Mergers and Acquisitions (M&As)
Overview
Key Announced Deals in M&As
Terminated M&As
Asset Swaps
Key Asset Swaps
Partnerships
Overview
Key Announced Deals
Terminated Partnerships
Licensing
Overview
Key Announced Deals
Terminated Licensing deals
Overview of Pharmaceutical Deals from 2010 to 2016
Pharmaceutical Deals by Value and Year
Number of Deals by Region/Country
Number of Deals by Prominent Therapy Area
Number of Deals by Stage of Development
Number of Deals by Molecule Type
Number of deals and Value by Type of Deal
Key Players
Conclusions and Future Scope
Bibliography